Physician profile
Mansoor Arain
NPI 1649531625
$23,750.60
in general payments reported to CMS, 2019-2025
16 companies · $1,234 in 2025
The $1,234 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $5,183 · 2021: $940 · 2022: $643 · 2023: $1,243 · 2024: $15K · 2025: $1,234.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $13K · Food and Beverage: $3,352 · Travel and Lodging: $733.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $12,900.00 |
| Food and Beverage | $3,351.67 |
| Travel and Lodging | $732.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $14,007.97 | 2022-2025 | Impella |
| Medtronic Vascular, INC. | $5,182.65 | 2020 | |
| Edwards Lifesciences Corporation | $1,162.07 | 2022-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Philips North America LLC | $1,029.04 | 2022-2024 | (Bq9) Coronary Ivus, (P84) Igt Devices Systems |
| Boston Scientific Corporation | $873.73 | 2021-2025 | Rotablator Rotational Atherectomy System Console Kit, Watchman Access System, Synergy |
| Abbott Laboratories | $745.46 | 2021-2025 | Mitraclip, Triclip, Xience Skypoint |
| Medtronic, INC. | $483.42 | 2021-2025 | Ffrangio, Corevalve Evolut R, Aurora Ev-Icd Mri Surescan |
| Novartis Pharmaceuticals Corporation | $61.19 | 2022-2023 | |
| Biosense Webster, INC. | $42.75 | 2024 | Qdot Micro Catheter |
| Janssen Pharmaceuticals, INC | $41.62 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $35.53 | 2022-2025 | Lifevest |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.05 | 2022 | |
| Becton, Dickinson and Company | $20.31 | 2025 | True Flow |
| Cardiva Medical, INC. | $16.69 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astrazeneca Pharmaceuticals LP | $15.89 | 2024 | Wainua |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $11.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mansoor Arain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.